Megha Garg

Internal Medicine
4150 Clement St
San Francisco, CA 94121

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis.

A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis.

Journal: Seminars in arthritis and rheumatism
Published: June 14, 2017
Showing 1-1 of 1

Last Updated: 09/26/2026